Cambodia vs North Korea: Women's share of population ages 15+ living with HIV
Cambodia
48.1%
in 2024
North Korea
48.1%
in 2024
Cambodia rank
52nd
North Korea rank
53rd
Women's share of population ages 15+ living with HIV over time
- Cambodia
- North Korea
How they compare
Cambodia currently reports 48.1% against 48.1% in North Korea, a difference of 0.0%.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was North Korea ahead.
Cambodia ranks 52nd and North Korea ranks 53rd of 172 countries.
Across the 4 decades both report, Cambodia averaged higher in 3 and North Korea in 1.
Head to head by decade
| Decade | Cambodia | North Korea | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 43.6% | 48.4% | 4.8% | North Korea |
| 2000s | 52.1% | 48.8% | 3.3% | Cambodia |
| 2010s | 52.7% | 48.5% | 4.1% | Cambodia |
| 2020s | 49.3% | 48.2% | 1.1% | Cambodia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher women's share of population ages 15+ living with hiv, Cambodia or North Korea?
- Cambodia, at 48.1% against 48.1% in North Korea as of 2024.
- What is the difference in women's share of population ages 15+ living with hiv between Cambodia and North Korea?
- 0.0%, with Cambodia ahead.
- How many years of comparable data are there for Cambodia and North Korea?
- 35 years are reported by both, from 1990 to 2024.
- How do Cambodia and North Korea rank globally for women's share of population ages 15+ living with hiv?
- Cambodia ranks 52nd and North Korea ranks 53rd of 172 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Women's share of population ages 15+ living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of HIV is the percentage of people who are infected with HIV. Female rate is as a percentage of the total population ages 15+ who are living with HIV.